Eledon Pharmaceuticals, Inc.
ELDN· Nasdaq
Released Nov 14, 2022, after the close
10-Q filed Nov 14, 2022, 45 days after period end · 0000950170-22-025007
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$10.47M | -$9.82M | -$6.14M | -$2.89M |
| EPS Diluted | -$0.73 | -$0.66 | -$5.51 | -$4.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR